Docality.com Logo
 
Dr. Avishai  Mendelson  Md image

Dr. Avishai Mendelson Md

4700 N Congress Ave Suite 301
West Palm Beach FL 33407
561 216-6898
Medical School: University Of Miami School Of Medicine - 1993
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: Yes
Participates In EHR: Yes
License #: ME68465
NPI: 1760476477
Taxonomy Codes:
207R00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Avishai Mendelson is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:G0438 Description:PPPS, initial visit Average Price:$524.00 Average Price Allowed
By Medicare:
$172.77
HCPCS Code:99204 Description:Office/outpatient visit new Average Price:$358.00 Average Price Allowed
By Medicare:
$170.20
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$225.00 Average Price Allowed
By Medicare:
$108.93
HCPCS Code:G0179 Description:MD recertification HHA PT Average Price:$133.00 Average Price Allowed
By Medicare:
$42.67
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$153.00 Average Price Allowed
By Medicare:
$73.84
HCPCS Code:G0008 Description:Admin influenza virus vac Average Price:$75.00 Average Price Allowed
By Medicare:
$25.42
HCPCS Code:99212 Description:Office/outpatient visit est Average Price:$92.00 Average Price Allowed
By Medicare:
$44.70
HCPCS Code:93000 Description:Electrocardiogram complete Average Price:$67.00 Average Price Allowed
By Medicare:
$20.17
HCPCS Code:Q2038 Description:Fluzone vacc, 3 yrs & >, im Average Price:$40.00 Average Price Allowed
By Medicare:
$12.44
HCPCS Code:85610 Description:Prothrombin time Average Price:$17.00 Average Price Allowed
By Medicare:
$5.56
HCPCS Code:82962 Description:Glucose blood test Average Price:$10.00 Average Price Allowed
By Medicare:
$3.32

HCPCS Code Definitions

99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
99212
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
93000
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
Q2038
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
99204
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.
G0008
Administration of influenza virus vaccine
G0438
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
G0179
Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implementation of the plan of care that meets patient's needs, per re-certification period

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1841245917
Internal Medicine
775
1972561553
Diagnostic Radiology
434
1740266337
Orthopedic Surgery
198
1669412136
Diagnostic Radiology
166
1053369413
Diagnostic Radiology
134
1649333816
Diagnostic Radiology
106
1467492934
Diagnostic Radiology
100
1881678464
Internal Medicine
78
*These referrals represent the top 10 that Dr. Mendelson has made to other doctors

Publications

Validation of a single-patient drug trial methodology for personalized management of gastroesophageal reflux disease. - Journal of managed care pharmacy : JMCP
Single-patient trials (SPTs) are randomized, often multiple-crossover trials where patients serve as their own control to determine their appropriate treatment. Historically, SPTs have been individually customized, requiring significant time and cost for execution. The patient.s progress is tracked and evaluated in a blinded, multiple-crossover design comparing different therapies. Standardized, cost-efficient SPTs could help avoid (a) inappropriate extrapolation of the average-group outcomes from parallel, clinical trials to community-practice patients and (b) wasteful prescribing of high-cost drugs. Aggregate SPT results can also provide new data on appropriate drug prescribing in subpopulations.To validate a standardized, commercially useful SPT method for comparing drugs/doses in patients with gastroesophageal reflux disease (GERD) requiring maintenance therapy.A double-blind, single-dummy, randomized, 3 paired-period (28 days per period, 14 days per leg), multiple-crossover, SPT comparing omeprazole 20 mg daily and ranitidine hydrochloride (ranitidine) 150 mg twice daily was employed for 32 patients with GERD taking acid-suppressing medications chronically. Endpoints to determine effectiveness were selected from a recently approved new-drug application. Heartburn, regurgitation, difficulty swallowing, epigastric pain, and nausea were evaluated daily. Use of rescue medications was also measured. Quality of life was measured weekly by the patient.s global evaluation. Observations for days 1 to 4 were excluded by using aggregate database sensitivity analyses to define appropriate surrogate washout periods. Frequently reported adverse events found in labeling for acid-suppressing drugs were directly solicited and compared between treatments. Unsolicited events were recorded. Patients completed a test-kit-acceptability questionnaire.Fourteen of 27 evaluable SPTs (52%) showed significant superiority for omeprazole over ranitidine and 7 of 27 (26%) for ranitidine over omeprazole. Four of 27 (15%) showed parity performance. Neither agent could be recommended in 2 of 27 (7%) of SPTs due to significant adverse events experienced with both drugs. For those patients taking proton pump inhibitors (PPIs) prior to enrollment, the estimated step-down substitution rate from omeprazole to ranitidine, combined with the drug therapy discontinuation rate, was 40% (90% confidence interval: 22% to 68%). The majority of patients rated the test kits as appropriate and desirable.Omeprazole was the appropriate treatment in only 52% of these chronic users of acid-suppressing drugs. Eleven of 27 trials (41%) indicated that ranitidine was the preferred treatment. The SPT method proved acceptable to patients, feasible to administer, and reproducible. It can statistically discriminate effectiveness and adverse events and serve as a useful, prognostic tool in community practice by determining the least costly, evidence-based, appropriate treatment.

Map & Directions

4700 N Congress Ave Suite 301 West Palm Beach, FL 33407
View Directions In Google Maps

Nearby Doctors

5325 Greenwood Ave Suite 201
West Palm Beach, FL 33407
561 449-9858
927 45Th St Suite 303
West Palm Beach, FL 33407
561 815-5454
2201 45Th St
West Palm Beach, FL 33407
561 426-6141
4700 N Congress Ave Suite 201
West Palm Beach, FL 33407
561 812-2640
2201 45Th St
West Palm Beach, FL 33407
561 647-7511
5205 Greenwood Ave Suite 251
West Palm Beach, FL 33407
561 488-8701
901 45Th St St Mary's Hospital, Nicu
West Palm Beach, FL 33407
561 406-6220
5325 Greenwood Ave Suite 304
West Palm Beach, FL 33407
561 401-1960
2201 45Th St
West Palm Beach, FL 33407
561 814-4365
2201 45Th St
West Palm Beach, FL 33407
561 633-3910